HCW Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.1	4.67	3.6	22.33	11.73	8.46
Short-Term Investments	-	-	-	9.74	24.98	-
Cash & Short-Term Investments	1.1	4.67	3.6	32.06	36.71	8.46
Cash Growth	9.89%	30.03%	-88.79%	-12.67%	334.19%	14.95%
Accounts Receivable	0.03	0.58	1.54	0.42	-	2.5
Other Receivables	-	-	-	-	0.13	-
Receivables	0.03	0.58	1.54	0.42	0.13	2.5
Prepaid Expenses	0.21	0.33	1.04	1.39	2.2	0.54
Other Current Assets	0.25	0.11	0.23	0.2	1.44	0.65
Total Current Assets	1.59	5.7	6.4	34.07	40.48	12.15
Property, Plant & Equipment	22.5	22.91	20.45	10.8	1.12	1.62
Long-Term Investments	1.33	1.6	1.6	1.6	11.52	1.6
Other Long-Term Assets	0.03	0.03	0.06	0.33	0.39	0.03
Total Assets	25.45	30.24	28.51	46.81	53.51	15.4
Accounts Payable	18.97	22.33	6.17	1.23	0.22	0.16
Accrued Expenses	1.08	0.98	2.43	1.55	0.3	0.28
Short-Term Debt	6.81	6.31	-	-	-	0.57
Current Portion of Long-Term Debt	-	-	0.12	-	-	-
Current Portion of Leases	-	-	0.03	0.18	-	-
Current Unearned Revenue	-	-	-	-	1.8	-
Total Current Liabilities	26.86	29.63	8.75	2.96	2.32	1
Long-Term Debt	-	7.38	6.3	6.41	-	-
Long-Term Leases	-	-	-	0.01	-	-
Total Liabilities	27.55	37.01	15.05	9.38	2.32	1
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	107.13	93.78	83.99	82.96	81.83	-
Retained Earnings	-109.24	-100.56	-70.53	-45.54	-30.64	-16.72
Total Common Equity	-2.11	-6.77	13.46	37.43	51.19	-16.72
Shareholders' Equity	-2.11	-6.77	13.46	37.43	51.19	14.4
Total Liabilities & Equity	25.45	30.24	28.51	46.81	53.51	15.4
Total Debt	6.81	13.69	6.45	6.6	-	0.57
Net Cash (Debt)	-5.71	-9.02	-2.86	25.46	36.71	7.89
Net Cash Growth	-	-	-	-30.65%	365.41%	7.24%
Net Cash Per Share	-3.78	-9.30	-3.18	28.43	78.24	66.58
Filing Date Shares Outstanding	2.7	1.12	0.95	0.9	0.89	0.12
Total Common Shares Outstanding	2.62	1.11	0.9	0.9	0.89	0.12
Working Capital	-25.27	-23.93	-2.34	31.11	38.16	11.15
Book Value Per Share	-0.80	-6.08	14.95	41.73	57.25	-139.51
Tangible Book Value	-2.11	-6.77	13.46	37.43	51.19	-16.72
Tangible Book Value Per Share	-0.80	-6.08	14.95	41.73	57.25	-139.51
Land	-	2.15	2.15	2.15	-	-
Buildings	-	6.11	6.11	6.11	-	-
Machinery	-	2.66	2.66	2.62	2.42	2.37
Construction In Progress	-	13.55	10.44	0.05	-	-
Leasehold Improvements	-	0.35	0.35	0.35	0.35	0.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q